Skip to main navigation
Skip to search
Skip to main content
University of Arizona Home
Home
Profiles
Departments and Centers
Scholarly Works
Activities
Grants
Datasets
Prizes
Search by expertise, name or affiliation
Nitrosourea combinations in lung cancer
R. B. Livingston
Research output
:
Contribution to journal
›
Article
›
peer-review
5
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Nitrosourea combinations in lung cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Lung Cancer
100%
Nitrosourea
100%
Multiple Drugs
50%
Cyclophosphamide
33%
Drug Combination
33%
Myelosuppression
16%
Methyl
16%
Drug Regimen
16%
Response Rate
16%
Therapeutic Index
16%
Adriamycin
16%
Methotrexate
16%
Bleomycin
16%
Comparative Trial
16%
Alkylating Agents
16%
Squamous Lung Cancer
16%
Lung Cancer Treatment
16%
Oat Cell Carcinoma
16%
Reduced Dose
16%
Bronchogenic Carcinoma
16%
Lung Adenocarcinoma
16%
Two-drug Combination
16%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Cancer
100%
Nitrosourea
100%
Combination Drug
66%
Cyclophosphamide
33%
Disease
16%
Therapeutic Window
16%
Bone Marrow Suppression
16%
Adenocarcinoma
16%
Doxorubicin
16%
Methotrexate
16%
Alkylating Agent
16%
Lomustine
16%
Bleomycin
16%
Vincristine
16%
Small Cell Carcinoma
16%
Lung Carcinoma
16%
Carmustine
16%
Semustine
16%